BACKGROUND: A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described. Missense mutations in sporadic coronary artery disease patients were also reported. These data suggest that mutations in exons 7 and 11 of MEF2A cause CAD/MI, though the association was refuted by another study. OBJECTIVE: To analyse the genetic variation of exons 7 and 11 in a large cohort of Spanish CAD/MI patients and controls. METHODS AND RESULTS: A rare polymorphism, P279L, was detected both in patients and controls. Carriers of the 279Leu allele had a threefold risk of suffering CAD/MI compared with controls (p = 0.009; odds ratio = 3.06 (95% confidence interval, 1.17 to 8.06)). In the controls the allele was found only in those under 50 years of age. Exon 11 showed a high degree of heterogeneity caused by a polyglutamine (CAG)n polymorphism, but no significant differences in genotype or allelic frequencies were found. CONCLUSIONS: The 279Leu allele appears to be a genetic risk factor for CAD/MI in the population studied. This effect could be the result of a reduced transcriptional activity on MEF2A with 279Leu.
BACKGROUND: A myocyte enhancer factor 2A (MEF2A) mutation that segregated with coronary artery disease/myocardial infarction (CAD/MI) in a large family has recently been described. Missense mutations in sporadic coronary artery diseasepatients were also reported. These data suggest that mutations in exons 7 and 11 of MEF2A cause CAD/MI, though the association was refuted by another study. OBJECTIVE: To analyse the genetic variation of exons 7 and 11 in a large cohort of Spanish CAD/MI patients and controls. METHODS AND RESULTS: A rare polymorphism, P279L, was detected both in patients and controls. Carriers of the 279Leu allele had a threefold risk of suffering CAD/MI compared with controls (p = 0.009; odds ratio = 3.06 (95% confidence interval, 1.17 to 8.06)). In the controls the allele was found only in those under 50 years of age. Exon 11 showed a high degree of heterogeneity caused by a polyglutamine (CAG)n polymorphism, but no significant differences in genotype or allelic frequencies were found. CONCLUSIONS:The 279Leu allele appears to be a genetic risk factor for CAD/MI in the population studied. This effect could be the result of a reduced transcriptional activity on MEF2A with 279Leu.
Authors: Li Weng; Nihan Kavaslar; Anna Ustaszewska; Heather Doelle; Wendy Schackwitz; Sybil Hébert; Jonathan C Cohen; Ruth McPherson; Len A Pennacchio Journal: J Clin Invest Date: 2005-04 Impact factor: 14.808
Authors: Francisco J Naya; Brian L Black; Hai Wu; Rhonda Bassel-Duby; James A Richardson; Joseph A Hill; Eric N Olson Journal: Nat Med Date: 2002-10-15 Impact factor: 53.440
Authors: M R Krishna Bhagavatula; Chun Fan; Gong-Qing Shen; June Cassano; Edward F Plow; Eric J Topol; Qing Wang Journal: Hum Mol Genet Date: 2004-10-20 Impact factor: 6.150
Authors: Gloriana V Trujillo; Dalea H Nodal; Candice V Lovato; Jill D Hendren; Lynda A Helander; TyAnna L Lovato; Rolf Bodmer; Richard M Cripps Journal: Dev Biol Date: 2016-03-13 Impact factor: 3.582
Authors: Eliecer Coto; Jorge Santos-Juanes; Pablo Coto-Segura; Marta Díaz; Javier Soto; Rubén Queiro; Victoria Alvarez Journal: BMC Med Genet Date: 2010-03-23 Impact factor: 2.103